Transfer of Her-2/neu specificity into Cytokine-Induced Killer (CIK) cells with RNA encoding Chimeric Immune Receptor (CIR)

Journal of Clinical Immunology

Volumn 29, Issue 6, 2009, Pages 806-814

  Yoon, Sung Hee ^a   Lee, Jin Myung ^a   Woo, Sun Je ^a   Park, Min Ji ^a   Park, Jung Sun ^a   Kim, Hye Sung ^a   Park, Mi Young ^a   Sohn, Hyun Jung ^a   Kim, Tai Gyu ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Chimeric immune receptor; CIK; Her 2 neu; RNA electroporation; Xenograft

Indexed keywords

ANTIGEN; CD28 ANTIGEN; CD3 ANTIBODY; CD3 ANTIGEN; CD56 ANTIGEN; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOLOGIC AGENT; INTERLEUKIN 2; NATURAL KILLER CELL RECEPTOR NKG2D; RNA; TRASTUZUMAB; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CANCER INHIBITION; CANCER THERAPY; CELL STRAIN K 562; CELL STRAIN MCF 7; CELL TRANSFER; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; ELECTROPORATION; FEMALE; GENE; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; KILLER CELL; MOUSE; NONHUMAN; NUDE MOUSE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RNA TRANSPORT; SKOV3 GENE; TUMOR CELL LINE; XENOGRAFT;

ADOPTIVE TRANSFER; ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELLS, CULTURED; CYTOKINE-INDUCED KILLER CELLS; CYTOTOXICITY, IMMUNOLOGIC; ELECTROPORATION; HUMANS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; RECEPTOR, ERBB-2; RNA; SINGLE-CHAIN ANTIBODIES; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 72849131418     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-009-9308-6     Document Type: Article

References (31)

1. IG Schmidt-Wolf S Finke B Trojaneck A Denkena P Lefterova N Schwella HG Heuft G Prange M Korte M Takeya T Dorbic A Neubauer B Wittig D Huhn 1999 Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma Br J Cancer 81 1009 1016 10.1038/sj.bjc.6690800 1:CAS:528:DyaK1MXnvFSjsL4%3D 10576658 (Pubitemid 29516145)
2. IG Schmidt-Wolf RS Negrin HP Kiem KG Blume IL Weissman 1991 Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity J Exp Med 174 139 149 10.1084/jem.174.1.139 1:CAS:528:DyaK3MXltFamsbY%3D 1711560
3. E Carbone P Neri M Mesuraca MT Fulciniti T Otsuki D Pende V Groh T Spies G Pollio D Cosman L Catalano P Tassone B Rotoli S Venuta 2005 HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells Blood 105 251 258 10.1182/blood-2004-04-1422 1:CAS:528:DC%2BD2MXis1Gquw%3D%3D 15328155 (Pubitemid 40053090)
4. W Cao X Xi Z Hao W Li Y Kong L Cui C Ma D Ba W He 2007 RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity J Biol Chem 282 18922 18928 10.1074/jbc. M702504200 1:CAS:528:DC%2BD2sXmvVarsbk%3D 17470428 (Pubitemid 47100170)
5. MR Verneris M Karami J Baker A Jayaswal RS Negrin 2004 Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells Blood 103 3065 3072 10.1182/blood-2003-06-2125 1:CAS:528:DC%2BD2cXjsVags70%3D 15070686 (Pubitemid 38451682)
6. JK Chan CA Hamilton MK Cheung M Karimi J Baker JM Gall S Schulz SH Thorne NN Teng CH Contag LG Lum RS Negrin 2006 Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study Clin Cancer Res 12 1859 1867 10.1158/1078-0432.CCR-05-2019 1:CAS:528:DC%2BD28Xis1Cjsb8%3D 16551871
7. F Tita-Nwa G Moldenhauer M Herbst C Kleist AD Ho M Kornacker 2007 Cytokine-induced killer cells targeted by the novel bispecific antibody CD19xCD5 (HD37xT5.16) efficiently lyse B-lymphoma cells Cancer Immunol Immunother 56 19 10.1007/s00262-007-0333-0 (Pubitemid 47512612)
8. V Marin E Dander E Biagi M Introna G Fazio A Biondi G D'Amico 2006 Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy Exp Hematol 34 1219 1229 10.1016/j.exphem.2006.05.004 1:CAS:528: DC%2BD28XovVSrsLk%3D 16939815 (Pubitemid 44291496)
9. D Ferber 2001 Gene therapy: safer and virus-free? Science 294 1638 10.1126/science.294.5547.1638 1:CAS:528:DC%2BD3MXosleqtLw%3D 11721029 (Pubitemid 33104814)
10. S Hacein-Bey-Abina C Von Kalle M Schmidt MP McCormack N Wulffraat P Leboulch 2003 LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 Science 302 415 419 10.1126/science.1088547 1:CAS:528:DC%2BD3sXotV2isb4%3D 14564000 (Pubitemid 37296260)
11. C Baum O Kustikova U Modlich Z Li B Fehse 2006 Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors Hum Gene Ther 17 253 263 10.1089/hum.2006.17.253 1:CAS:528:DC%2BD28XisFWgu7o%3D 16544975
12. AW Nienhuis CE Dunbar BP Sorrentino 2006 Genotoxicity of retroviral integration in hematopoietic cells Mol Ther 13 1031 1049 10.1016/j.ymthe.2006. 03.001 1:CAS:528:DC%2BD28XltFClsbw%3D 16624621 (Pubitemid 43779188)
13. M Van Sonja S Lieven H Carlo D Melissa G De Catherine T Van Viggo 2002 Efficient genetic modification of murine dendritic cells by electroporation with mRNA Cancer Gene Ther 9 787 797 10.1038/sj.cgt.7700499 (Pubitemid 34971310)
14. Y Zhao Z Zheng CJ Cohen L Gattinoni DC Palmer NP Restifo 2006 High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation Mol Ther 13 151 159 10.1016/j.ymthe.2005.07.688 1:CAS:528:DC%2BD2MXhtlShsrvE 16140584 (Pubitemid 41763493)
15. A Ohshita Y Yamaguchi K Minami R Okita T Toge 2006 Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients Int J Oncol 28 1163 1171 1:CAS:528: DC%2BD28Xks1Cisr8%3D 16596232
16. SH Yoon JM Lee HI Cho EK Kim HS Kim MY Park TG Kim 2008 Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model Cancer Gene Ther 16 489 497 10.1038/cgt.2008.98 19096447
17. DJ Slamon GM Clark SG Wong WJ Levin A Ullrich WL McGuire 1987 Human breast cancer: correlation of relapse and survival with amplification of the HER2-2/neu oncogene Science 235 177 182 10.1126/science.3798106 1:CAS:528:DyaL2sXhtVSht7s%3D 3798106
18. J Baselga J Mendelsohn 1994 Receptor blockade with monoclonal antibodies as anti-cancer therapy Pharmacol Ther 64 127 154 10.1016/0163-7258(94)90036-1 1:CAS:528:DyaK2cXmvFymtL8%3D 7846112 (Pubitemid 24324177)
19. HA Lane I Beuvink AB Motoyama JM Daly RM Neve NE Hynes 2000 ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency Mol Cell Biol 20 3210 3223 10.1128/MCB.20.9.3210-3223.2000 1:CAS:528: DC%2BD3cXivFSrsrk%3D 10757805 (Pubitemid 30215033)
20. J Baselga 2001 Clinical trials of Herceptin (trastuzumab) Eur J Cancer 37 18 24 10.1016/S0959-8049(00)00404-4 11342196
21. DJ Slamon B Leyland-Jones S Shak H Fuchs V Paton A Bajamonde 2001 Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 783 792 10.1056/ NEJM200103153441101 1:CAS:528:DC%2BD3MXisVGktrc%3D 11248153 (Pubitemid 32222155)
22. MW Teng MH Kershaw M Moeller MJ Smyth PK Darcy 2004 Immunotherapy of cancer using systemically delivered gene-modified human T lymphocytes Hum Gene Ther 15 699 708 10.1089/1043034041361235 1:CAS:528:DC%2BD2cXlsFajs7o%3D 15242530 (Pubitemid 38925222)
23. N Kato J Tanaka J Sugita T Toubai Y Miura M Ibata Y Syono S Ota T Kondo M Asaka M Imamura 2007 Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells Leukemia 21 2103 2108 10.1038/sj.leu.2404862 1:CAS:528:DC%2BD2sXhtVGmsb7K 17625602 (Pubitemid 47423800)
24. A Rölle M Mousavi-Jazi M Eriksson J Odeberg C Söderberg- Nauclér D Cosman K Kärre C Cerboni 2003 Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein J Immunol 171 902 908 12847260
25. DM Heimann LM Weiner 2007 Monoclonal antibodies in therapy of solid tumors Surg Oncol Clin N Am 16 775 792 10.1016/j.soc.2007.07.001 18022544 (Pubitemid 350101273)
26. CM Kowolik MS Topp S Gonzalez T Pfeiffer S Olivares N Gonzalez DD Smith SJ Forman MC Jensen LJ Cooper 2006 CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells Cancer Res 66 10995 11004 10.1158/0008-5472.CAN-06-0160 1:CAS:528:DC%2BD2sXivVyqt70%3D 17108138 (Pubitemid 44876999)
27. J Wang M Jensen Y Lin X Sui E Chen CG Lindgren B Till A Raubitschek SJ Forman X Qian S James P Greenberg S Riddell OW Press 2007 Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains Hum Gene Ther 18 712 725 10.1089/hum.2007.028 1:CAS:528:DC%2BD2sXpsV2kurw%3D 17685852 (Pubitemid 47378068)
28. E Verhoeyen V Dardalhon O Ducrey-Rundquist D Trono N Taylor FL Cosset 2003 IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes Blood 101 2167 2174 10.1182/blood-2002-07-2224 1:CAS:528:DC%2BD3sXit1egsL8%3D 12446448 (Pubitemid 36302054)
29. C Hsu SA Jones CJ Cohen Z Zheng K Kerstann J Zhou PF Robbins PD Peng X Shen TJ Gomes CE Dunbar DJ Munroe C Stewart K Cornetta D Wangsa T Ried SA Rosenberg RA Morgan 2007 Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene Blood 109 5168 5177 10.1182/blood-2006-06-029173 1:CAS:528: DC%2BD2sXmslOrsrs%3D 17353346 (Pubitemid 46890533)
30. M Dagarag T Evazyan N Rao RB Effros 2004 Genetic manipulation of telomerase in HIV-specific CD8+ T cells: enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization J Immunol 173 6303 6311 1:CAS:528:DC%2BD2cXpt1Olt78%3D 15528369
31. H Fujisaki H Kakuda C Imai CG Mullighan D Campana 2009 Replicative potential of human natural killer cells Br J Haematol 145 606 613 10.1111/j.1365-2141.2009.07667.x 1:CAS:528:DC%2BD1MXmvFyjur8%3D 19344420